ENANTA PHARMACEUTICALS INC·4

Feb 13, 7:58 PM ET

MELLETT PAUL J 4

4 · ENANTA PHARMACEUTICALS INC · Filed Feb 13, 2023

Insider Transaction Report

Form 4
Period: 2023-02-09
MELLETT PAUL J
Treasurer and CFO
Transactions
  • Sale

    Common Stock

    2023-02-09$53.64/sh4,200$225,28884,263 total
  • Sale

    Common Stock

    2023-02-09$54.41/sh800$43,52883,463 total
Footnotes (3)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in December 2022.
  • [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $53.09 to $54.05, inclusive.
  • [F3]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $54.09 to $54.85, inclusive.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES